Efficacy and safety of nusinersen in children with later-onset spinal muscular atrophy (SMA): interim results of the phase 3 CHERISH study

被引：0
|
作者：
Finkel, Richard
Mercuri, Eugenio
Kirschner, Jan
Chiriboga, Claudia A.
Kuntz, Nancy
Darras, Basil T.
Shieh, Perry B.
Saito, Kayoko
De Vivo, Darryl
Day, John W.
Mazzone, Elena S.
Montes, Jacqueline
Yang, Qingqing
Zhong, Zhenshao John
Gheuens, Sarah
Bennett, C. Frank
Schneider, Eugene
Farwell, Wildon
机构：
来源：
NEUROLOGY | 2017年 / 89卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：E100 / E101
页数：2
相关论文
共 50 条
  • [41] Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study
    De Vivo, Darryl C.
    Bertini, Enrico
    Swoboda, Kathryn J.
    Hwu, Wuh-Liang
    Crawford, Thomas O.
    Finkel, Richard S.
    Kirschner, Janbernd
    Kuntz, Nancy L.
    Parsons, Julie A.
    Ryan, Monique M.
    Butterfield, Russell J.
    Topaloglu, Haluk
    Ben-Omran, Tawfeg
    Sansone, Valeria A.
    Jong, Yuh-Jyh
    Shu, Francy
    Staropoli, John F.
    Kerr, Douglas
    Sandrock, Alfred W.
    Stebbins, Christopher
    Petrillo, Marco
    Braley, Gabriel
    Johnson, Kristina
    Foster, Richard
    Gheuens, Sarah
    Bhan, Ishir
    Reyna, Sandra P.
    Fradette, Stephanie
    Farwell, Wildon
    NEUROMUSCULAR DISORDERS, 2019, 29 (11) : 842 - 856
  • [42] Interim report on the safety and efficacy of longer-term treatment with nusinersen in infantile-onset spinal muscular atrophy: results from the SHINE study
    Castro, D.
    Farrar, M.
    Finkel, R.
    Tulinius, M.
    Krosschell, K.
    Saito, K.
    Zhang, Y.
    Bhan, I.
    Farwell, W.
    Reyna, S.
    NEUROMUSCULAR DISORDERS, 2018, 28 : S79 - S80
  • [43] Plasma neurofilament light chain in Chinese children with later-onset spinal muscular atrophy
    Jin, Jianing
    Wei, Jia
    Feng, Yijie
    Cui, Yiqin
    Zhou, Dongming
    Yao, Mei
    He, Ni
    Mao, Zhifeng
    Gao, Feng
    Mao, Shanshan
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2022, 60 (10) : E237 - E239
  • [44] Nusinersen experience in later onset spinal muscular atrophy: A tertiary center
    Tuncer, G. Oz
    Mihci, F.
    Dolu, M.
    Akca, U.
    Aydin, S.
    Turk, S.
    Aksoy, A.
    Tasdemir, H.
    NEUROMUSCULAR DISORDERS, 2020, 30 : S71 - S71
  • [45] Baseline Characteristics and Initial Safety Results in RESPOND: A Phase 4 Study of Nusinersen in Children with Spinal Muscular Atrophy (SMA) Who Received Onasemnogene Abeparvovec
    Brandsema, John
    Parsons, Julie
    Proud, Crystal
    Finkel, Richard
    Swoboda, Kathryn
    Masson, Ricardo
    Liu, Yingying
    Makepeace, Corinne
    Paradis, Angela
    Berger, Zdenek
    Wagner, Joanne
    Somera-Molina, Kathleen
    NEUROLOGY, 2022, 98 (18)
  • [46] Study on the efficacy, safety, and biomarkers of nusinersen in type II and III spinal muscular atrophy in children
    Chen, Liyuan
    Liu, Fen
    Fang, Danna
    Li, Jianwei
    FRONTIERS IN PEDIATRICS, 2023, 11
  • [47] Nusinersen in infants who initiate treatment in a presymptomatic stage of spinal muscular atrophy (SMA): Interim results from the phase 2 nurture study
    Ryan, M. M.
    De Vivo, D. C.
    Bertini, E.
    Hwu, W. L.
    Crawford, T. O.
    Swoboda, K. J.
    Finkel, R. S.
    Kirschner, J.
    Kuntz, N. L.
    Parsons, J.
    Butterfield, R. J.
    Topaloglu, H.
    Ben Omran, T.
    Sansone, V. A.
    Jong, Y. J.
    Shu, F.
    Foster, R.
    Bhan, I.
    Fradette, S.
    Farwell, W.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [48] Nusinersen in infants who initiate treatment in a presymptomatic stage of Spinal Muscular Atrophy (SMA): interim results from the phase 2 NURTURE study
    Sansone, V. A.
    De Vivo, D. C.
    Bertini, E.
    Hwu, W. -L.
    Crawford, T. O.
    Swoboda, K. J.
    Finkel, R. S.
    Kirschner, J.
    Kuntz, N.
    Parsons, J.
    Ryan, M. M.
    Butterfield, R. J.
    Topaloglu, H.
    Ben Omran, T.
    Jong, Y. -J.
    Shu, F.
    Bevernage, S. P.
    Johnson, K.
    Foster, R.
    Bhan, I.
    Fradette, S.
    Farwell, W.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 83 - 83
  • [49] Nusinersen in Infants Who Initiate Treatment in a Presymptomatic Stage of Spinal Muscular Atrophy (SMA): Interim Results From the Phase 2 NURTURE Study
    Finkel, Richard S.
    De Vivo, Darryl C.
    Swoboda, Kathryn J.
    Bertini, Enrico
    Hwu, Wuh-Liang
    Foster, Richard
    Bhan, Ishir
    Fradette, Stephanie
    Farwell, Wildon
    NEUROLOGY, 2020, 94 (15)
  • [50] Interim Results of a Phase 2 Clinical Study of Nusinersen (ISIS-SMNRx) in Patients with Infantile-Onset Spinal Muscular Atrophy
    Finkel, Richard
    Chiriboga, Claudia
    Vajsar, Jiri
    Day, John
    Montes, Jacqueline
    De Vivo, Darryl
    Yamashita, Mason
    Rigo, Frank
    Hung, Gene
    Schneider, Eugene
    Norris, Daniel
    Xia, Shuting
    Bennett, Frank
    Bishop, Kathie
    NEUROLOGY, 2016, 86
12345